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Abstract—According to the American Diabetes Associa-
tion(ADA), 30.3 million people in the United States have diabetes,
but only 7.2 million may be undiagnosed and unaware of their
condition. Type 2 diabetes is usually diagnosed for most patients
later on in life whereas the less common Type 1 diabetes is
diagnosed early on in life. People can live healthy and happy
lives while living with diabetes, but early detection produces a
better overall outcome on most patient’s health. Thus, to test
the accurate prediction of Type 2 diabetes, we use the patients’
information from an electronic health records company called
Practice Fusion, which has about 10,000 patient records from
2009 to 2012. This data contains individual key biometrics,
including age, diastolic and systolic blood pressure, gender,
height, and weight. We use this data on popular machine learning
algorithms and for each algorithm, we evaluate the performance
of every model based on their classification accuracy, precision,
sensitivity, specificity/recall, negative predictive value, and F1
score. In our study, we find that all algorithms other than
Naive Bayes suffered from very low precision. Hence, we take a
step further and incorporate all the algorithms into a weighted
average or soft voting ensemble model where each algorithm
will count towards a majority vote towards the decision outcome
of whether a patient has diabetes or not. The accuracy of the
Ensemble model on Practice Fusion is 85%, by far our ensemble
approach is new in this space. We firmly believe that the weighted
average ensemble model not only performed well in overall
metrics but also helped to recover wrong predictions and aid
in accurate prediction of Type 2 diabetes. Our accurate novel
model can be used as an alert for the patients to seek medical
evaluation in time.
Index Terms—Type 2 Diabetes, Machine Learning, Ensemble
Model, Supervised Prediction, Medical Diagnosis
I. INTRODUCTION
In 2017, Center for Disease Control(CDC) 1 estimates 84
million adult Americans have a prediabetic condition, and
90% of them go undiagnosed. In 2018, according to the
American Diabetes Association(ADA) 2, 30.3 million people
in the United States have diabetes, but 7.2 million may be
undiagnosed and unaware of their condition. About 1.5 million
new cases of diabetes are diagnosed in the United States every
year. Type 2 diabetes is usually diagnosed for most patients
later on in life whereas the less common Type 1 diabetes is
diagnosed early on in life for most patients with the peak
1Center for Disease Control National Diabetes Statistics Report, 2017.
2American Diabetes Association Statistics, 2018.
age usually being around 14. People can live healthy happy
lives while living with diabetes, but early detection produces
a better overall effect for most patients health. Initial onset of
Type 2 diabetes can produce mild to no symptoms, so many
patients may not be diagnosed until 7-10 years after onset.
The uncontrolled high blood sugar damages nerves over time.
If left untreated, diabetic patients face an increased risk of
diabetic retinopathy which in turn leads to blindness, kidney
disease leading to renal failure, and nerve disease leading to
neuropathy and numbness in extremities among other serious
conditions. In this work, to test the accurate prediction of Type
2 diabetes, we started with raw data from an electronic health
records company called Practice Fusion and about 10,000
patient records from 2009 to 2012. We chose to focus on this
specific biometrics because there has been significant evidence
to show this may affect the determination of diabetes:
• Age: According to 2017 CDC report, the rate of diag-
nosed diabetes increased with age. Among adults ages
18-44, 45-64 years and 65 years and older, of about 4%,
17%, and 25% had diabetes. Further, according to 2018
ADA report, an estimated 11.7% of women (with a 95%
C.I.) have diabetes over the age of 18. A rated 12.7% of
men (with a 95% C.I.) have diabetes over the age of 18.
• Blood Pressure: According to 2017 CDC report, 73.6%
of those living with diabetes have a systolic blood pres-
sure of 140 mm Hg or higher and diastolic blood pressure
of 90 mm Hg or higher, and they were on prescription
medication for high blood pressure. It is a high-risk factor
of living with diabetes as it could lead to cardiovascular
problems.
• Height, Weight-BMI: According to National Institute of
Diabetes and Digestive and Kidney Diseases 3, experts
believe that obesity, especially visceral fat, is the primary
cause of insulin resistance.
Consequently, to test the accurate prediction of Type 2 di-
abetes, we build a supervised machine learning ensemble
model4 using seven standard classification algorithms: k-
Nearest Neighbors, Support Vector Machines, Decision Trees,
3Insulin Resistance and prediabetes from National Institute of Diabetes and
Digestive and Kidney Diseases
4Code and Datasets on GitHub Repository: Supervised Machine Learning
Ensemble Model for Type-2 Diabetes Prediction
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Random Forest, Gradient Boosting, MLP Neural Network, and
Naive Bayes. For each algorithm, we tune hyperparameters
to produce the best accuracy, and at the end, we evaluate
each model’s performance based on their classification accu-
racy, precision, sensitivity, specificity/recall, negative predic-
tive value, and F1 score.
Organization of this paper as follows: as Section 2 consists
of related work in this field. Section 3 explains, the proposed
approach along with problem formulation, datasets, and data
preparation, and the components and description ensemble
model. Section 4 describes the results and analysis of the
developed ensemble model. This section illustrates the em-
pirical study to determine the performance of every machine
learning algorithm used. Section 5 briefly concludes the paper
and followed by the future scope of extension.
II. RELATED WORK
Systematic literature conducted in [1] showed that machine
learning and data mining tools are applied in the field of
diabetes research concerning prediction and diagnosis, dia-
betic complications, genetic background and environment, and
health care management. In general, 85% of those characterize
supervised learning approaches and 15% by unsupervised
ones, and more specifically, with the association of different
rules. Support vector machines (SVM) is the most successful
and widely used algorithm. A novel update on race/ethnic
differences in children and adults with Type 1 diabetes, chil-
dren with Type 2 diabetes in Latino sub-populations reviewed
[2]. Studies conducted in [3], [4], [5], [6] have attempted to
produce a model for diabetes detection with machine learning.
An empirical study conducted in [7] observed that at one year,
intensive lifestyle intervention resulted in clinically significant
weight loss in people with Type 2 diabetes. This weight loss
associated with improved diabetes control and cardiovascular
disease risk factors and reduced medicine use in intensive
lifestyle intervention versus diabetes support and education.
Continued intervention and follow-up will determine whether
these changes are maintained and will reduce cardiovascular
disease risk. Diabetes Mellitus is a metabolic disease where
random blood glucose levels lead to the risk of many diseases
like heart attack, kidney disease, and renal failure. Diabetes
Mellitus diagnosed in [8] uses only K- Nearest neighbor algo-
rithm. On the other hand, diabetes complications are predicted
in [9] by embedding machine learning algorithms into data
mining pipelines, which can combine them with traditional
statistical strategies, to extract knowledge from data. In this
research, the missing information from the collected data is
dealt with utilizing random forest and applying the proper
approach to handle class imbalance and then used Logistic
Regression with stepwise feature selection to predict the onset
of retinopathy, neuropathy, or nephropathy, at different time
scenarios. That is, at 3, 5, and 7 years from the first visit at the
Hospital Center for Diabetes, but not from the diagnosis. This
method helped in the smooth translation of model assessment
to the clinical practice. The study conducted in [6] compared
the performance of supervised machine learning algorithms
that were used to predict diabetes. This study employed the
Pima Indians data set and k Nearest Neighbors, Decision
Trees, Random Forest, and SVM. Of the four classifiers,
Decision Tree was able to achieve the highest accuracy of
73.82%. After removing inconsistent/noisy data, they were
able to achieve 100% accuracy using the Random Forest algo-
rithm or k Nearest Neighbors algorithm with the k=1 neighbor.
However, there is no record of further performance tests. In
2018, [5] used three different machine learning classification
models such as Naive Bayes, Support Vector Machine, and
Decision Tree to predict diabetes. In their study, they found
that the Naive Bayes classification the highest accuracy of
76.30%. Unlike the previous works that focused either particu-
lar classifier-set or a Pima Indians dataset that is heavily biased
towards limited female population, we use a new approach
and dataset, yet use the Pima Indians dataset for baseline
comparison. That is, the ensemble method of machine learning
is our approach to predict Type 2 diabetes more accurately and
we use Practice Fusion Dataset. We firmly believe that the
weighted average ensemble model not only performed well in
overall metrics but also helped in recover wrong predictions.
While the accuracy of the previous works on Pima Indians
dataset was less than 80%, the accuracy of our Ensemble
model reached 89% for the same dataset. For Practice Fusion
dataset, due to different approaches of the winners of the
Kaggle competition, we were unable to accomplish one to one
comparison on model comparison unlike the previous dataset.
However, the accuracy of the Ensemble model on Practice
Fusion is 85%, by far our ensemble approach is new in this
space. Description of each of the classifiers, ensemble model
and their performance on Practice Fusion dataset are detailed
in the later sections, since that is the primary focus of this
work.
III. PROPOSED LEARNING APPROACH
We explored the data through seven machine learning al-
gorithms such as k Nearest Neighbors, Support Vector Ma-
chines, Decision Trees, Random Forest, Gradient Boosting,
Neural Network, and Naive Bayes. For each algorithm, we
perform hyperparameter tuning and then assess the models
performance with classification. Before performing ensemble
learning, we will look at the classification report for each
algorithm as shown in the block diagram in Fig 2. In this
section, we describe the data preparation for the standard
machine-learning models.
A. Data Preparation
In 2012, Practice Fusion, an electronic medical health
records company, released de-identified records for 9,948
patients across the United States on Kaggle in a competition to
build a diabetes detection model. For those patients, records
from years 2009 to 2012 include extensive information in-
cluding patient vitals at each medical office visit; have taken
medications, allergies, medical conditions, and lab results.
From this, we decided to filter the data to focus on patient
Fig. 1. Pair plot of differing variables after the data normalization of Practice Fusion dataset. SBP = Systolic Blood Pressure, DBP = Diastolic Blood Pressure,
Gender 1 = Female, Gender 0 = Male
weight, height, age, gender, diastolic and systolic blood pres-
sure, and BMI. For each patient in the data set, we replaced
all zeros in the data with NaN to be able to calculate the
mean with NaN mean function. From there, we estimate the
minimum, maximum, and average or mean values of weight,
height, BMI, and both diastolic and systolic blood pressure for
each patient for all of their vitals took over those four years.
So for each patient, we were comparing those 15 values in
addition to their age and gender for a total of 17 values, as
shown in Fig 1. There will also be one column that represents
the outcome of whether the patient has diabetes or not. Our
ultimate goal is to produce something that can help clinicians
predict diabetes for their patients, and ultimately these vitals
are the most convenient and prevalent to obtain for any patient.
For a baseline comparison, we use Pima Indians that is used by
previous works. This dataset is heavily biased towards female
population and has about 800 records. In particular for each
algorithm we calculate the following performance measures
along with the accuracy of each model, as accuracy is a hoax
measure if used alone to test the performance of any machine
learning model as shown in Table I.
• Sensitivity: Sensitivity will refer to the ratio that for
all patients that had diabetes, the percent the algorithm
classified as diabetic.
• Precision: Precision will refer to the ratio that for all the
predictions that a patient had diabetes, the percentage that
was diabetic.
• Negative Prediction: Negative predictive value refers to
the ratio of the predicted value of all patients being non-
diabetic, the percentage that was non-diabetic.
• Specificity: Specificity refers to the ratio that for all pa-
tients that were non-diabetic, the percentage the algorithm
classified as non-diabetic.
• F1-Score: F1 score is the harmonic mean of precision and
recall. It maintains a good balance of positive predictive
values and sensitivity.
IV. SUPERVISED LEARNING - ENSEMBLE MODEL
In this section, we explain the performance of every classi-
fier used for this prediction task, along with a brief description
of the utility of the mentioned standard classifiers.
A. K-Nearest neighbor
K-Nearest Neighbor(k-NN) [10] is a type of classification
algorithm that predicts the outcome of a data point based on
comparison to its closest neighbors’ outcomes. The k here
stands for the number of neighbors that the model is comparing
to. The k-Nearest neighbor algorithm will calculate the closest
or nearest neighbors to a data point by comparing the data
point’s variable values to the values of other points. It does this
by summing the distance of each variable in one data point and
each variable in another point in the set. The distance, in this
case, will be calculated with the Euclidean distance formula.
The closest points will have the smallest sums in comparison
to the data point. We compare our test point to k numbers of
closest neighbors and depending on whether that neighbor is
diabetic or not; it will affect the prediction of whether our point
is also diabetic. For example, if the K number of neighbors
is 3, we compare individual data point to the three closest
data points to it. Those 3 points each have an equal vote in
determining if the test point is diabetic or not. If for example,
2 of those points are diabetic and one is not diabetic, then our
prediction lean towards the individual being diabetic based
on a majority vote. Training and testing accuracy of KNN
with the cross-validation of KNN is as shown in Fig 3. After
cross-validating the data with k Fold testing, we found that
the optimal k neighbors to compare to was 41. The accuracy
of the model was about 81.5%, but the precision of the model
was very low at 6.1%, negative predictive value was high at
98.8%, sensitivity was 54%, and specificity was 82.1%. This
result shows that when the algorithm predicted that a patient
was non-diabetic, the algorithm was correct 98.8% of the time.
But, if a patient anticipated being diabetic, it was only right 6%
of the time. This result explains a low rate of false negatives
but a high rate of false positives, which is better than the
reverse as we instead a patient get tested for being diabetic
than stating that they were non-diabetic and being wrong as
that patient never get tested. F1 score for this model was 11%.
B. Support Vector Machines
Support Vector Machine(SVM) [11] is another machine
learning algorithm used towards classification. A support vec-
tor machine will divide a dataset into two classes, in our case
diabetic and non-diabetic, by separating it with the hyperplane
that best divides them. We consider a 2D data set with only
data points and one variable like gender being compared. SVM
creates a line/plane of the division to split the dataset so that
each gender is separated. Points closer to the plane will affect
the position of the plane. Once the plane has been placed,
we are more confident that points further from the plane were
correctly classified while points closer to the boundary, that
is less confident on correct classification. As we add more
and more variables for comparison, this plane becomes a
hyperplane of higher and higher dimensions to segregate our
data better. The importance of features is shown in Fig 4.
After normalizing our data, we performed parameter tuning
and found that a linear SVM with C of 1. The accuracy of the
model was about 81.1%, but the precision of the model was
extremely low at 0.5%, negative predictive value was high
at 99.6%, sensitivity was 25%, and specificity was 81.4%.
Again, like the previous algorithm, this shows that when our
predicted value, i.e., a patient was non-diabetic, the algorithm
was correct almost 100% of the time. But, if a patient was
predicted as diabetic, almost never correct. F1 score for this
algorithm was 1.05%.
C. Decision Tree
Decision Tree [12] is a supervised machine learning algo-
rithm also used towards classification. The classification model
is built in a tree structure. The data set is broken down into
smaller subsets that become nodes and inter nodes in the tree
structure. Each split is formed on a particular variable. Each
decision or root node can have two or more branches, and
each leaf node will represent classification. After parameter
tuning, we found that decision tree with a max tree depth
of 7 produced the best accuracy for the model at 79.2%.
While the feature importance for this algorithm is shown in 5
Accuracy is shown in Fig 6. The precision of the model was
still low but nowhere nearly as low as the previous models at
23.5%, negative predictive value was high at 92.0%, sensitivity
was 40.3%, and specificity was 84%. Compared to previous
models, we gained quite a bit of precision, sensitivity, and
Fig. 2. Block Diagram of Supervised Machine Learning Ensemble Model for Type 2 Diabetes Prediction
Fig. 3. Cross Validation error for K nearest Neighbors
Fig. 4. Feature Importance for Support Vector Machine.
Fig. 5. Feature Importance for Decision Tree
specificity but lost some of our negative predictive value. F1
score for this algorithm was 29.7%.
Fig. 6. Accuracy of Decision Tree
D. Random Forest
Random Forest [13] is an ensemble machine learning al-
gorithm used for classification. It starts with and uses de-
cision trees like previously, however, the model creates an
entire forest of random uncorrelated trees to arrive at the
classification decision. Multiple trees are created from multiple
training sets generated randomly with replacement. For each
tree, node splits are stopped by choosing only a random subset
of features at each split. This prunes each tree and produces
trees that are random and uncorrelated. Then when the model
makes a prediction, it will take the average of all decisions
that the individual trees in the forest make to come to a final
classification decision. After parameter tuning, we found that
a max tree depth of 9 and n-estimators of 250 trees in the
forest for decision making produced the most optimal result.
The accuracy of the model was about 82.4%. The precision
of the model was 12.4%, negative predictive value was high at
98.4%, sensitivity was 64%, and specificity was 83.0%. This
model produced the highest specificity so far, which combined
with the negative predictive value shows that when this model
predicts that a patient is non-diabetic, that is true 98.4% and
of the non-diabetic patients, 83% were classified correctly. F1
score for this algorithm was 20.7%.
E. Gradient Boosting
Gradient Boostingfriedman2001greedy is another ensemble
machine learning algorithm used for classification that uses
boosting to improve performance. We start by fitting an initial
decision tree to the data. After the first tree is evaluated, the
next tree is constructed to cover the difference between the
first tree and the actual target. It does so by reconstructing the
residual. This means that when combined with the previous
tree, it will minimize the overall prediction error. The next
tree will continue to do so with all previous trees so that in
the end each subsequent tree is optimizing the differentiable
loss function and taking a further step in the direction that
minimizes the prediction error based on the gradient of the
error concerning the prediction. After parameter tuning, we
found that a max tree depth of 3 produced the best accuracy
at 82.0%. The precision of the model was 15.3%, negative
predictive value was high at 97.4%, sensitivity was 57.0%,
and specificity was 83.4%. F1 score for this algorithm was
24.1%.
F. Neural Network
For our neural network algorithm, we used Multi-Layer
Perceptron Neural Networks(MLP). Neural networks [14] are
inspired by the way our human biological neural networks in
the brain works. It consists of neurons, weights, and activation
or transfer functions. A perceptron is a single neuron model.
Think of a neuron as a unit that receives input. Each input the
neuron receives is given a weight, and as it passes through
the neuron, the neuron or node applies the activation function
to the sum of the weighted inputs. Each activation function
performs a fixed mathematical operation on the sum of the
inputs. Multiple neurons are then connected in both the input
layer, hidden layer(s), and the output layer. A Multi-Layer
Perceptron Neural Network has one or more hidden layers
that can perform non-linear functions. MLP trains on data to
model the correlation between inputs and outputs by a constant
back and forth pass with the output layer being compared
against the actual true classification going forward. And then
the backward propagation with partial derivatives of the error
function with regards to various weights to move the MLP
closer and closer to error minimum. So inputs are moving
forward from one neuron to another, and multiple functions
are being applied to the sum of the inputs as it goes forward.
But it is also constantly evaluating and going backward to
adjusted weights and biases until it reaches optimum minimum
error and a final classification decision. Data was first scaled
as neural networks like this with deep learning expect all input
variables to vary in the same vary or similar way. Scaling the
data will produce a variance of 1 for all variables and mean
of 0. After that, we ran the algorithm and found that accuracy
was about 82.5%. The precision of the model was 18.3%,
negative predictive value was high at 97.3%, sensitivity was
60.7%, and specificity was 83.8%. F1 score for this algorithm
was 28.1%.
G. Naive Bayes
Naive Bayes is a probabilistic classification algorithm that
that is based on Bayes Theorem. Bayesian classifiers assign
the most likely class to a given sample described by its fea-
ture vector. The naive Bayes classifier [15] greatly simplifies
learning by assuming that features are independent of given
class, which can be formulated as
P(X |C) =∏
i
= 1nP(Xi|C),whereX = (X1,X2, ......,Xn)
. It works on conditional probability, the probability that
something will occur given that something else has already
occurred. Naive Bayes assumes that every variable being
classified is independent of any other variable i.e., predictors
are independent. So, this algorithm considers each variable to
contribute independently to the probability of the classification
being either diabetic or non-diabetic. The algorithm will
calculate the posterior probability for each class using the
Naive Bayesian equation, and the class with high posterior
probability will be the outcome. This is fairly simplistic
compared to some of the other models that we have tried,
but sometimes a simpler model may work better. In this case,
however, it did not. Accuracy for this algorithm was the lowest
of all models at 66.4%. The precision of the model was higher
at 66.4%, but the negative predictive value was much lower at
66.4%. Sensitivity was 31.2%, and specificity was 89.6%. F1
score for this algorithm was 42.4%. Performance of individual
classifiers for Pima Indian and Practice Fusion datasets are
shown in 8, II and 7, I respectively. As from the Table I,
we can observe that most classification algorithms performed
well with about 80-82% accuracy other than the Naive Bayes.
However, all algorithms other than Naive Bayes also suffered
from a very low precision meaning that of the patients that are
actually classified as diabetic, there is a very low chance of
them being diabetic. That means that there are a lot of false
positives being reported. Conversely, the negative predictive
value for the classifiers is all very high and consistently higher
than 90% meaning that when the algorithms classify a patient
as non-diabetic, they are very sure that the patient is actually
non-diabetic.
H. Ensemble Model
Always, it is better for us to have more false positives in this
case than false negatives because as far as diabetes detection
goes, we rather a patient get tested than ignore testing thinking
they do not have diabetes. So we will take it one step further
by implementing a Weighted Average Ensemble model. Of the
classification algorithms above, we will create an ensemble
model that will take the result of each algorithm in the model,
multiply it by the weight assigned to the algorithm and then
sum the result to determine the final classification outcome as
shown in Fig 2. To implement this, we first select the models
Practice Fusion Dataset
Classifier- Performance K-NN SVM Decision Tree Random Forest Gradient Boosting Neural Network Naive Bayes
Accuracy 0.8151 0.8114 0.7923 0.8238 0.8204 0.8254 0.6643
Precision 0.0610 0.0054 0.2352 0.1239 0.1526 0.1831 0.6643
Negative Prediction 0.9881 0.9963 0.9201 0.9843 0.9736 0.9728 0.6433
Sensitivity 0.5396 0.2500 0.4031 0.6449 0.5705 0.6071 0.3122
Specificity 0.8210 0.8137 0.8399 0.8304 0.8336 0.8385 0.8961
F1-Score 0.1097 0.0105 0.2971 0.2078 0.2408 0.2814 0.4248
TABLE I
OVERALL PERFORMANCE OF INDIVIDUAL CLASSIFIERS FOR PRACTICE FUSION DATASET
Pima Indians Dataset
Classifier- Performance K-NN SVM Decision Tree Random Forest Gradient Boosting Neural Network Naive Bayes
Accuracy 0.6941 0.3427 0.7260 0.7123 0.6849 0.3425 0.6803
Precision 0.2800 1.000 0.6400 0.5067 0.3733 1.000 0.3467
Negative Prediction 0.9097 0.000 0.7708 0.8194 0.8472 0.000 0.8542
Sensitivity 0.6176 0.3425 0.5926 0.5938 0.5600 0.3425 0.5532
Specificity 0.7081 0.635 0.8043 0.7613 0.7219 0.7152 0.7151
F1-Score 0.3853 0.0105 0.6154 0.5468 0.4480 0.5102 0.4262
TABLE II
OVERALL PERFORMANCE OF INDIVIDUAL CLASSIFIERS FOR PIMA INDIANS DATASET
Classifier- Performance Practice Fusion Pima Indians
Accuracy 0.860 0.891
Precision 0.242 0.769
Negative Prediction 0.992 0.958
Sensitivity 0.884 0.909
Specificity 0.847 0.884
F1-Score 0.380 0.833
TABLE III
OVERALL PERFORMANCE OF ENSEMBLE MODEL ON PRACTICE FUSION AND PIMA INDIAN DATASETS
Fig. 7. Classification Performance of Machine Learning Algorithms for
Practice Fusion Dataset
that we like to combine and then we run an optimization model
to see what weights to assign to each model to produce the
highest final accuracy. First, we take all models except for
Naive Bayes, and after running them through optimization
for log loss, we find that optimal ensemble model involve
a combined model of SVM, Random Forest, and Gradient
Boosting for Practice Fusion dataset and a combined model
of KNN, Random Forest, and Gradient Boosting for Pima
Indian dataset. The optimized weights of both these datasets
are 0.073, 0.902, 0.023 and 3.262, 5.431, 5.453 respectively.
After running the combined ensemble consisting of these
three algorithms with weights, the accuracy did increase to
Fig. 8. Classification Performance of Machine Learning Algorithms Pima
Indians Dataset
85%. Precision was 24.2%, Negative predictive value 99.3%,
Sensitivity 88.5%, and Specificity 84.7%. F1 score was 38.0%.
Overall performance of the Ensemble on Practice Fusion and
Pima Indians are shown in III.
V. CONCLUSION AND FUTURE WORK
The supervised ensemble model in this work will help
determine whether a patient may have diabetes or at high risk
of developing diabetes. All algorithms other than Naive Bayes
also suffered from a very low precision meaning that of the
patients that are actually classified as diabetic, there is a very
low chance of them being diabetic. That means that there are a
lot of false positives being reported. Conversely, the negative
predictive value for the classifiers is all very high and con-
sistently higher than 90% meaning that when the algorithms
classify a patient as non-diabetic, they are very, very sure that
the patient is non-diabetic. Weighted Average Ensemble model
performed better in recovering wrong predictions. Unlike the
previous works that focused either particular classifier-set or
a Pima Indians dataset that is heavily biased towards limited
female population, we use a new approach and dataset, yet
use the Pima Indians dataset for the baseline comparison.
While the accuracy of the previous works on Pima Indians
dataset was less than 80%, the accuracy of our Ensemble
model reached 89% for the same dataset. The accuracy of
the Ensemble model on Practice Fusion is 85%, by far our
ensemble approach is new in this space. We firmly believe
that the weighted average ensemble model not only performed
well in overall metrics but also helped in recover wrong
predictions and aid in accurate prediction of Type2 diabetes.
Our accurate novel model can be used as an alert for the
patients to seek medical evaluation in time. Clinicians could
use the tool to determine whether they should test a patient
earlier for diabetes with the industry standard HBA1c [16]test,
which measures glycated hemoglobin and long-term average
plasma glucose concentration. The model could ultimately be
made available for direct patient use with a more limited set
of biometrics and be used as an alert to patients to seek
medical evaluation in time. Similarly, this decision support
system may also be implemented by larger health entities
like health care systems or public health systems with more
biometrics to quickly look at a large population and see how
many people may have diabetes and decide on larger long-term
health implementations from there.
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